MedPage Today on MSN
New CMS demo aims to increase access to GLP-1s under Medicaid and Part D
The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback